For example, 18F-deoxyglucose positron emission tomography was applied for the detection of the early response to the B-Raf proto-oncogene, serine/threonine kinase (BRAF) inhibitor, vemurafenib, in BRAF-mutant melanoma patients (9). The gene discussed is BRAF; the disease is melanoma.